http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4220636-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5005ad9aa4e180781b0066027ad47f62 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02 |
| filingDate | 1978-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1980-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36dbcafc2414c8b3e1fb36d53a7bb346 |
| publicationDate | 1980-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4220636-A |
| titleOfInvention | Stabilized suppositories containing ergo-alkaloids |
| abstract | The present invention relates to stabilized suppositories containing ergo-alkaloids and/or their derivatives, characterized in that SO2-releasing substances are added in a finely dispersed state to the suppositories in amounts of 0.2 to 5 mg per suppository. The invention provides a safe route for the treatment of migraine not affected by nausea, which often occurs with the condition. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4929640-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6598371-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8909599-A1 |
| priorityDate | 1978-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.